EAP VERSUS OLEX STUDY
Both an Open Label Extension (OLEX) study and an Expanded Access Program (EAP) can be used to provide continued treatment access after phase 3 clinical trials have ended. In some cases, an OLEX study would be the appropriate choice. However, in others, an EAP can be used as a time- and cost-effective alternative.
To help companies understand both programs and consider which would be the best option for their post-phase 3 efforts, WEP Clinical has created useful table outlining the main differences between an OLEX study and an EAP. Please complete the form below to download the resource.
Please provide your name and email address in the fields below and press the download button. You should then receive the table as a pdf in a new tab in your browser. You will also receive a link to the template in your email inbox, so you can access it again later.